Criterion and construct validity of the cogstate schizophrenia battery in japanese patients with schizophrenia

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Yoshida, Taisuke ^a,b   Suga, Motomu ^c   Arima, Kunimasa ^d   Muranaka, Yasuko ^e   Tanaka, Tsunehiko ^f   Eguchi, Satoshi ^c   Lin, Crystal ^d   Yoshida, Sumiko ^d   Ishikawa, Masanori ^d   Higuchi, Yuko ^e   Seo, Tomonori ^e   Ueoka, Yoshinori ^f   Tomotake, Masahito ^f   Kaneda, Yasuhiro ^g   Darby, David ^h   Maruff, Paul ^h   Iyo, Masaomi ^b   Kasai, Kiyoto ^c   Higuchi, Teruhiko ^d   Sumiyoshi, Tomiki ^e   Ohmori, Tetsuro ^f   Takahashi, Kiyohisa ⁱ   Hashimoto, Kenji ^a   more..

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

^g Iwaki Clinic   (Japan)

^h Iwaki Clinic ^*  (Australia)

ⁱ The Japan Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; COGSTATE SCHIZOPHRENIA BATTERY; CONSTRUCT VALIDITY; CONTROLLED STUDY; CRITERION VARIABLE; FEMALE; GENDER; HUMAN; INTELLIGENCE QUOTIENT; JAPANESE; MALE; MEMORY; PSYCHOMETRY; SCHIZOPHRENIA; SOCIAL COGNITION; ASIAN; CASE CONTROL STUDY; COGNITION; DEMOGRAPHY; JAPAN; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; TIME;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COGNITION; DEMOGRAPHY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; TIME FACTORS; YOUNG ADULT;

EID: 79957562563     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020469     Document Type: Article

References (41)

1. Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, et al. (1994) Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 51: 124-131.
2. Censits DM, Ragland JD, Gur RC, Gur RE, (1997) Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res 24: 289-298.
3. Green MF, Kern RS, Heaton RK, (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72: 41-51.
4. Green MF, (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153: 321-330.
5. Green MF, Nuechterlein KH, (1999) Should schizophrenia be treated as a neurocognitive disorder? Schizophr Bull 25: 309-319.
6. Hyman SE, Fenton WS, (2003) Medicine. What are the right targets for psychopharmacology? Science 299: 350-351.
7. Hashimoto K, Koike K, Shimizu E, Iyo M, (2005) α7 Nicotinic receptor agonists as potential therapeutic drugs for schizophrenia. Curr Med Chem CNS Agents 5: 171-184.
8. Buchanan RW, Freedman R, Javitt DC, Abi-Dargham A, Lieberman JA, (2007) Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull 33: 1120-1130.
9. Hashimoto K, (2011) Glycine transporter-1: a new potential target for schizophrenia. Curr Pham Des 17: 112-120.
10. Ishikawa M, Hashimoto K, (2011) α7 nicotinic receptor: a potential therapeutic target for schizophrenia. Curr Pharm Des 17: 121-129.
11. Kern RS, Green MF, Nuechterlein KH, Deng BH, (2004) NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res 72: 11-19.
12. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, et al. (2008) The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165: 203-213.
13. Buchanan RW, Keefe RS, Umbricht D, Green MF, Laughren T, et al. (2011) The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later? Schizophr Bull in press.
14. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, et al. (2004) The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68: 283-297.
15. Kaneda Y, Sumiyoshi T, Keefe RS, Ishimoto Y, Numata S, et al. (2007) Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci 61: 602-609.
16. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, et al. (2004) Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 56: 301-307.
17. Keefe RS, Harvey PD, Goldberg TE, Gold JM, Walker TM, et al. (2008) Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr Res 102: 108-115.
18. Maruff P, Thomas E, Cysique L, Brew B, Collie A, et al. (2009) Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol 24: 165-178.
19. Pietrzak RH, Olver J, Norman T, Piskulic D, Maruff P, et al. (2009) A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. J Clin Exp Neuropsychol 31: 848-859.
20. Addington D, Addington J, Schissel B, (1990) A depression rating scale for schizophrenics. Schizophr Res 3: 247-251.
21. Kaneda Y, Ohmori T, Addington D, (2000) [The Japanese version of the Calgary Depression Scale for Schizophrenics (JCDSS)]. No To Shinkei 52: 163-166.
22. Matsuoka K, Uno M, Kasai K, Koyama K, Kim Y, (2006) Estimation of premorbid IQ in individuals with Alzheimer's disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin Neurosci 60: 332-339.
23. Kay SR, Fiszbein A, Opler LA, (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276.
24. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, et al. (1997) Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120 (Pt 10): 1823-1843.
25. Lim YY, Prang KH, Cysique L, Pietrzak RH, Snyder PJ, et al. (2009) A method for cross-cultural adaptation of a verbal memory assessment. Behav Res Methods 41: 1190-1200.
26. Pinkham AE, Sasson NJ, Calkins ME, Richard J, Hughett P, et al. (2008) The other-race effect in face processing among African American and Caucasian individuals with schizophrenia. Am J Psychiatry 165: 639-645.
27. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, et al. (2009) The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21: 672-687.
28. Bralet MC, Falissard B, Neveu X, Lucas-Ross M, Eskenazi AM, et al. (2007) Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients. Eur Psychiatry 22: 365-370.
29. Jurado MB, Rosselli M, (2007) The elusive nature of executive functions: a review of our current understanding. Neuropsychol Rev 17: 213-233.
30. Sullivan JR, Riccio CA, Castillo CL, (2009) Concurrent validity of the tower tasks as measures of executive function in adults: a meta-analysis. Appl Neuropsychol 16: 62-75.
31. Snyder PJ, Jackson CE, Piskulic D, Olver J, Norman T, et al. (2008) Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication. Psychiatry Res 160: 316-326.
32. Allen DN, Strauss GP, Donohue B, van Kammen DP, (2007) Factor analytic support for social cognition as a separable cognitive domain in schizophrenia. Schizophr Res 93: 325-333.
33. Shamsi S, Lau A, Lencz T, Burdick KE, Derosse P, et al. (2011) Cognitive and symptomatic predictors of functional disability in schizophrenia. Schizophr Res 126: 257-264.
34. Pinkham AE, Penn DL, (2006) Neurocognitive and social cognitive predictors of interpersonal skill in schizophrenia. Psychiatry Res 143: 167-178.
35. Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, et al. (2011) The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neurosci Biobehav Rev 35: 573-588.
36. Seltzer J, Conrad C, Cassens G, (1997) Neuropsychological profiles in schizophrenia: paranoid versus undifferentiated distinctions. Schizophr Res 23: 131-138.
37. Goldstein G, Shemansky WJ, Allen DN, (2005) Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia. Arch Clin Neuropsychol 20: 153-159.
38. Brazo P, Marie RM, Halbecq I, Benali K, Segard L, et al. (2002) Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry 17: 155-162.
39. Falleti MG, Maruff P, Collie A, Darby DG, (2006) Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol 28: 1095-1112.
40. Pietrzak RH, Snyder PJ, Jackson CE, Olver J, Norman T, et al. (2009) Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals. Hum Psychopharmacol 24: 113-121.
41. Keefe RS, Fox KH, Harvey PD, Cucchiaro J, Siu C, et al. (2011) Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res 125: 161-168.